Looking to validate existing assays to meet requirements for new IVDR guidelines?
Discovery Life Sciences has samples across a range of various assays.
Meet your deadline for
the new IVDR guidelines.
Utilize Discovery’s biospecimen inventory and global support team to:
- Build diverse validation cohorts
- Accelerate biospecimen delivery
- Achieve your validation timelines
including fully consented biospecimens and matched sets
collected longitudinally with comprehensive patient data.
Remnant sets can include
- Swabs in media –Nasopharyngeal, Throat
- Whole Blood
- Plasma
- Serum
- Sputum
- Urine
Matched sets can include
- Plasma = EDTA plasma 1 ml processed next day with Discovery protocol.
- Serum = SST Serum 1ml processed next day with Discovery protocol.
- PBMCs = 1million (viable cells) processed next day with Discovery protocol
- Saliva collected in FDA authorized Spectrum DNA Solutions S1000 kits
Comprehensive Patient Data can include
- Gender
- Age at diagnosis
- OB
- Race
- Ethnicity if known
- Smoking history
- Alcohol history
- Treatment history
- Blood type
- Clinical confirmed COVID-19 positive
- Real-time RT-PCR, Antibody testing, etc. with dates
- Other test results with dates, if available
- Date of First Signs/Symptoms
- Signs and symptoms
- Health history or Medical conditions (past and current)
- Outcomes information in follow up data – deceased, released/recovered etc.
Let us know your biospecimen needs, and our team will help you source from our global inventory.